Biopsy News and Research

RSS

Biopsy is the removal of cells or tissues for examination by a pathologist. The pathologist may study the tissue under a microscope or perform other tests on the cells or tissue. There are many different types of biopsy procedures. The most common types include: (1) incisional biopsy, in which only a sample of tissue is removed; (2) excisional biopsy, in which an entire lump or suspicious area is removed; and (3) needle biopsy, in which a sample of tissue or fluid is removed with a needle. When a wide needle is used, the procedure is called a core biopsy. When a thin needle is used, the procedure is called a fine-needle aspiration biopsy.

Researchers explore how evolutionary processes guide pathways of cells

Evolution describes how all living forms cope with challenges in their environment, as they struggle to persevere against formidable odds. Mutation and selective pressure--cornerstones of Darwin's theory--are the means by which organisms gain an advantageous foothold or pass into oblivion.

23 Feb 2018

3D Signatures reports positive results of new Telo-HL test for Hodgkin's lymphoma

3D Signatures Inc. is pleased to announce that a preliminary third-party analysis of the trial data for Telo-HL, 3DS' test in development for Hodgkin's lymphoma (HL), shows that the Company's TeloViewTM platform is able to distinguish, with a high degree of statistical significance, multiple differences between a patient group that responds to standard ABVD chemotherapy, and a group that relapses or is refractory to treatment within the first 12 months.

22 Feb 2018

Advanced method holds promise for substantial improvements in breast cancer diagnosis

Enhancing the diagnosis of breast cancer is the stated goal of a research team at the German Cancer Research Center in Heidelberg. The scientists have combined an advanced method of diffusion-weighted MR imaging with intelligent image analysis methods to detect malignant changes in tissues.

21 Feb 2018

Research project aims to find new ways to identify and treat most aggressive brain cancers

A large European research collaboration is bringing new technology to bear to combat two of the most aggressive brain cancers.

21 Feb 2018

Study: Diagnosis of celiac disease takes 3.5 years for patients who do not report GI symptoms

It takes an average of 3.5 years to diagnose celiac disease in patients who do not report gastrointestinal symptoms, a Loyola Medicine study has found.

19 Feb 2018

Liquid biopsies could be used as new predictive marker for metastatic TNBC

A clinically relevant "liquid biopsy" test can be used to profile cancer genomes from blood and predict survival outcomes for patients with metastatic triple negative breast cancer, according to new research published by a multi-institutional team of researchers with The Ohio State University Comprehensive Cancer Center -- Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, the Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard.

19 Feb 2018

Amyloid protein may be transmitted through neurosurgical instruments, study suggests

Amyloid beta pathology - protein deposits in the brain - might have been transmitted by contaminated neurosurgical instruments, suggests a new UCL-led study.

15 Feb 2018

New scanning technology could reduce number of biopsies on people with fatty liver disease

A study jointly led by the University of Birmingham and University of Edinburgh has revealed that a new scanning technology could almost halve the number of liver biopsies carried out on people with fatty liver disease.

13 Feb 2018

Researchers describe human blood-nerve barrier transcriptome for the first time

Human peripheral nerves -- all the nerves outside of the central nervous system -- are protected by the blood-nerve barrier. This is a tight covering of endothelial cells that maintains the microenvironment within the nerves by restricting the amounts or types of water, ions, solutes and nutrients that can reach the axons, or electric cables within the nerves, from the blood circulation system.

8 Feb 2018

German researchers find way to accurately differentiate prostate cancer from benign tissue

Using nuclear medicine, German researchers have found a way to accurately differentiate cancerous tissue from healthy tissue in prostate cancer patients. The research is highlighted in the February issue of The Journal of Nuclear Medicine.

6 Feb 2018

Early and targeted treatment of dnDSA preserves allograft function

Development of de novo donor-specific antibodies (dnDSA) is known to cause graft failure. Therefore, a protocol aimed at prospective monitoring and treating dnDSA--before it can cause graft damage--was developed for kidney transplant recipients at Children National Health System.

5 Feb 2018

Researchers evaluate need for biopsies during follow-up care for breast cancer patients

In an analysis of more than 120,000 women diagnosed with and treated for early-stage breast cancer, researchers from The University of Texas MD Anderson Cancer Center determined the rate of additional breast biopsies needed for these patients during their follow-up care.

31 Jan 2018

Researchers turn to new biomarkers for predicting organ transplant rejection

Organ transplants save lives, but the story doesn't end when a patient emerges from the operating room. Rejection episodes, in which the immune system rallies against the new organ, can occur.

31 Jan 2018

Expert panel releases updated guidelines for lung cancer molecular testing

Lung cancer treatment often pairs targeted therapies with genetic alterations driving the disease. This makes detecting these genetic alterations an essential step in diagnosis.

30 Jan 2018

New AASLD guideline focuses on improving diagnosis, treatment of liver cancer and NAFLD

A new Practice Guideline and Practice Guidance in Hepatology will help improve the diagnosis and treatment of patients with liver cancer as well as patients with non-alcoholic fatty liver disease (NAFLD), which can lead to liver cancer and is characterized by the build-up of extra fat in liver cells often due to obesity and diabetes.

27 Jan 2018

CureMatch’s co-founder is co-author of new article in Cancer Discovery journal

Igor F. Tsigelny, Ph.D., Co-founder and Chief Strategic Officer at CureMatch and research professor at University of California, San Diego, is a co-author of “Genomic landscape of cell-free DNA in patients with colorectal cancer” in Cancer Discovery along with group of colleagues from Duke University Medical Center, University of Texas MD Anderson Cancer Center, Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, Caris Life Sciences, and Guardant Health, Inc. organized by the Drs. Ryan B. Corcoran and Scott Kopetz.

27 Jan 2018

IPF Catalyst Challenge recognizes Owlstone Medical’s Breath Biopsy platform

Owlstone Medical Ltd, a diagnostics company developing a breathalyzer for disease, today announced it is one of the three winners of the global Idiopathic Pulmonary Fibrosis (IPF) Catalyst Challenge, sharing the $1,000.000 (£720,000 GBP) award, each receiving $333,333 (£240,000 GBP).

27 Jan 2018

Biopsy News and Research

Further Reading

Researchers explore how evolutionary processes guide pathways of cells

3D Signatures reports positive results of new Telo-HL test for Hodgkin's lymphoma

Advanced method holds promise for substantial improvements in breast cancer diagnosis

Research project aims to find new ways to identify and treat most aggressive brain cancers

Study: Diagnosis of celiac disease takes 3.5 years for patients who do not report GI symptoms

Liquid biopsies could be used as new predictive marker for metastatic TNBC

Amyloid protein may be transmitted through neurosurgical instruments, study suggests

New scanning technology could reduce number of biopsies on people with fatty liver disease

Researchers describe human blood-nerve barrier transcriptome for the first time

German researchers find way to accurately differentiate prostate cancer from benign tissue

Early and targeted treatment of dnDSA preserves allograft function

Researchers evaluate need for biopsies during follow-up care for breast cancer patients

Researchers turn to new biomarkers for predicting organ transplant rejection

Expert panel releases updated guidelines for lung cancer molecular testing

New AASLD guideline focuses on improving diagnosis, treatment of liver cancer and NAFLD

CureMatch’s co-founder is co-author of new article in Cancer Discovery journal

IPF Catalyst Challenge recognizes Owlstone Medical’s Breath Biopsy platform

Leading medical societies update molecular testing guideline for lung cancer

Analysis finds overlooked crucial factor in determining prognosis for DIPGs

When you need a breast screening, should you get a 3-D mammogram?

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News